[{"data":1,"prerenderedAt":84},["ShallowReactive",2],{"drug-cabergoline":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":36,"contraindications":61,"warnings":71,"renal":72,"monitoring":73,"interactions":74,"review":75,"examples":78},"cabergoline",1,{"fa":7,"en":8},"کابرگولین","Cabergoline","endocrine",{"fa":11,"en":12},"آگونیست دوپامین","Dopamine agonist",[14],{"name":15,"market":16},"Dostinex","US",[18,19,7,20],"dostinex","دوستینکس","پرولاکتین",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-0-5","tablet","oral","0.5 mg tablet (scored)",{"amount":28,"unit":29,"perUnit":24,"scored":30},0.5,"mg",true,[16],[33],{"source":34,"section":35},"fda-cabergoline","3",[37],{"id":38,"disease":39,"label":40,"population":43,"type":47,"unit":29,"dose":48,"refs":50,"notes":53},"prl","hyperprolactinemia",{"fa":41,"en":42},"هیپرپرولاکتینمی — ۰٫۲۵ mg دو بار در هفته","Hyperprolactinaemia — 0.25 mg twice weekly",{"minAge":44},{"value":45,"unit":46},18,"year","fixed",{"perDose":49,"dosesPerDay":5},0.25,[51],{"source":34,"section":52},"2.2",[54],{"text":55,"refs":58},{"fa":56,"en":57},"دو بار در هفته (نه روزانه). افزایش ۰٫۲۵ mg دو بار در هفته با فاصله‌ها تا طبیعی شدن پرولاکتین.","Twice weekly (not daily). Increase by 0.25 mg twice weekly at intervals until prolactin normalises.",[59],{"source":34,"section":60},"2",[62],{"id":63,"severity":64,"text":65,"refs":68},"ci","block",{"fa":66,"en":67},"فشار خون کنترل‌نشده؛ حساسیت به مشتقات ارگوت؛ سابقه بیماری دریچه قلب؛ سابقه فیبروز ریه، پریکارد یا رتروپریتوئن.","Uncontrolled hypertension; hypersensitivity to ergot derivatives; history of cardiac valvulopathy; history of pulmonary, pericardial or retroperitoneal fibrosis.",[69],{"source":34,"section":70},"4",[],[],[],[],{"status":76,"reviewer":77,"date":77},"unverified",null,[79],{"regimen":38,"formulation":23,"input":80,"expect":83},{"ageYears":81,"weightKg":82},30,60,{"perDose":49,"tabletsPerDoseRounded":28},1792078532407]